Bill Information for HB 3414 


HB 3414 by Phillips and Paxton

Select Session:  

Enter Bill #:                 

Receive Email Updates for this Measure (LENS)

 

Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.

History




Amendments




Bill Summaries




Versions




Votes




Authors/Co Authors

History For HB 3414

Action
 Journal Page
 Date
 Chamber
First Reading 51 02/07/2022 H
Authored by Representative Pae 51 02/07/2022 H
Second Reading referred to Public Health 198 02/08/2022 H
CR; Do Pass, amended by committee substitute Public Health Committee 248 02/16/2022 H
Coauthored by Representative(s) Phillips, Rosecrants, McEntire, Martinez, Dempsey, Dollens, Humphrey, Echols, Talley, McDugle, Davis 248 02/16/2022 H
Authored by Senator Paxton (principal Senate author) 248 02/16/2022 H
General Order 332 03/07/2022 H
Coauthored by Representative(s) Manger, Walke, Brewer, Munson 332 03/07/2022 H
House Rule suspended 332 03/07/2022 H
Amended by floor substitute 332 03/07/2022 H
Third Reading, Measure passed and Emergency failed: Ayes: 62 Nays: 30; Ayes: 66 Nays: 25 333 03/07/2022 H
Referred for engrossment 334 03/07/2022 H
Engrossed, signed, to Senate 337 03/08/2022 H
First Reading 423 03/08/2022 S
Second Reading referred to Health and Human Services 674 03/24/2022 S
Reported Do Pass, amended by committee substitute Health and Human Services committee; CR filed 747 04/11/2022 S
Title stricken 747 04/11/2022 S
remove as coauthor Representative(s) Phillips 772 04/14/2022 S
remove as principal author Representative Pae and substitute with Representative Phillips 772 04/14/2022 S
Coauthored by Representative Pae 772 04/14/2022 S
 
Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105